Author: Ryan Holtz

Ryan Holtz is a Senior Editor at Tech Insider covering Technology & Services sector stocks. His coverage universe includes Chinese Internet stocks in the eCommerce and online video sectors, Chinese online games stocks, as well as education companies. Holtz previously lived in Hong Kong for four years where he served in a dual role as head of Piper Jaffray Asia equity research and senior research analyst covering Chinese stocks. Before joining TI, Ryan was a management consultant at Deloitte & Touche LLC, where he worked in the financial services group.
BioTech

Is InterMune (NASDAQ:ITMN) a Takeover Candidate?

InterMune (NASDAQ:ITMN) March 34 and 35 calls are active on total call volume 3,100 contracts (500 puts) on attracting takeover interest, Reuters says. March call option implied volatility is at 90, April is at 88, May and July is at 82; compared to its 26-week average of 90 according to Track Data. Active call volume suggests traders taking positions for price movement, according to theflyonthewall.com. … Continue reading Is InterMune (NASDAQ:ITMN) a Takeover Candidate?

Ryan Holtz
BioTech

Peregrine Pharmaceuticals (NASDAQ:PPHM) Up 20% to 19-Month High; Agenus (NASDAQ:AGEN) Soars

Peregrine Pharmaceuticals (NASDAQ:PPHM) is up nearly 20% and reached a 19-month high after the biopharmaceutical company said Wednesday that it will present data from three preclinical studies highlighting the immuno-oncology and anti-viral potential of phosphatidylserine (PS)-targeting antibodies. Results will be presented at two upcoming Keystone Symposia to be held March 9-13. Shares of Peregrine (NASDAQ:PPHM) are at $2.29, and earlier touched $2.37 – its highest price … Continue reading Peregrine Pharmaceuticals (NASDAQ:PPHM) Up 20% to 19-Month High; Agenus (NASDAQ:AGEN) Soars

Ryan Holtz
Finance, Internet, Mobile

Tech Runners: Apple Inc. (NASDAQ:AAPL), Nokia Corporation (ADR) (NYSE:NOK), Tesla Motors Inc (NASDAQ:TSLA), BlackBerry Ltd (NASDAQ:BBRY)

Apple Inc. (NASDAQ:AAPL) is hiring hundreds of new engineers and supply-chain managers in China and Taiwan as it attempts to speed product development and introduce a wider range of devices. Apple Inc. (NASDAQ:AAPL) stock performance was 0.29% in last session and finished the day at $527.76. Traded volume was 8,516,392 million shares in the last session and the average volume of the stock remained 12.69 … Continue reading Tech Runners: Apple Inc. (NASDAQ:AAPL), Nokia Corporation (ADR) (NYSE:NOK), Tesla Motors Inc (NASDAQ:TSLA), BlackBerry Ltd (NASDAQ:BBRY)

Ryan Holtz
Stock Movers

Afternoon Movers: LDR Holding (LDRH), Endologix (ELGX), Nelnet Inc. (NNI)

LDR Holding (NASDAQ:LDRH) is higher, climbing to an all-time high Friday, after the company reported late Thursday that for Q4, revenues topped Street forecasts while its loss widened year over year and missed estimates. Despite the mixed results, shares are up 7.98% at $31.14, and hit a record high of $31.59. The global media device company reported a Q4 loss of $0.69 per share, compared … Continue reading Afternoon Movers: LDR Holding (LDRH), Endologix (ELGX), Nelnet Inc. (NNI)

Ryan Holtz
Diversified Tech

After-Hours Earnings Highlights: Mentor Graphics (NASDAQ:MENT), (NASDAQ:FSTR), (NASDAQ:CHUY), (NASDAQ:MNST)

Mentor Graphics (NASDAQ:MENT) is steady after hours Thursday after it edges out the Street view with Q4 earnings and provides mixed guidance. The company reports non-GAAP income of $107 million or $0.92 per share compared to $67 million or $0.58 per share a year earlier. The company reports Q4 revenues of $401 million, up from $331 million a year earlier. The analysts consensus in the … Continue reading After-Hours Earnings Highlights: Mentor Graphics (NASDAQ:MENT), (NASDAQ:FSTR), (NASDAQ:CHUY), (NASDAQ:MNST)

Ryan Holtz
Analysis, BioTech, business, Earnings

Aegerion Pharmaceuticals (NASDAQ:AEGR) Curbs Losses in Quarter

Aegerion Pharmaceuticals (NASDAQ:AEGR) is lower after it reported a Q4 loss that was smaller than analysts had expected and set a FY14 sales guidance that straddled estimates. Shares are down 11.48% at $58.73 with a 52-week range of $28.33 – $101.00. In the quarter, the biopharmaceutical company had a non-GAAP loss of $0.14 per share, down from a loss of $0.71 the year earlier and … Continue reading Aegerion Pharmaceuticals (NASDAQ:AEGR) Curbs Losses in Quarter

Ryan Holtz